Loading clinical trials...
Loading clinical trials...
The purpose of this study is to test a treatment that tries to reduce the amount of fluid in the lungs of subjects with acute lung injury to see if this is helpful.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oregon Health and Science University
Collaborators
NCT06750536 · Extracorporeal Membrane Oxygenation Complication, Neonatal Aspiration Pneumonia, and more
NCT06805409 · Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
NCT07225257 · Sepsis, Acute Lung Injury(ALI)
NCT06444750 · Transfusion-Related Acute Lung Injury, ARDS, Human
NCT07145814 · Acute Lung Injury(ALI)
Kaiser Permanente Sunnyside
Clackamas, Oregon
Legacy Good Samaritan
Portland, Oregon
Oregon Health and Science University
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions